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1. Introduction
Chances are relatively high that each of us will experience low back pain at some point in our
lives. The usual course is rapid improvement with 5% to 10% developing persistent symp‐
toms [1]. In the 1990s the estimated cost of low back pain to the health industry was in the billions
of dollars, and with a larger proportion of our population now reported to be older, this number
can only be expected to increase [2,3]. Treatment typically begins with conservative measures
such as medication and physical therapy and may even include minimally and highly inva‐
sive pain management interventions. Surgery is sometimes required in patients who have
progressive  neurologic  deficits  or  those  who  do  not  respond  to  conservative  treatment
sometimes chose surgery. A quandary sometimes arises, following a primary surgery, as to
whether repeat surgery should be attempted or another alternative technique should be tried.
This is the exact problem that the epidural adhesiolysis procedure was designed to address.
Failed back surgery or postlaminectomy syndrome led to the development of the epidural
adhesiolysis procedure. It was shown to be effective in many patients with chronic pain after
back surgery presumably by freeing up nerves and breaking down scar formation, delivering
site-specific corticosteroids and local anesthetics, and reducing edema with the use of hyaluro‐
nidase and hypertonic saline. Epidural adhesiolysis has afforded patients a reduction in pain
and neurologic symptoms without the expense and occasional long recovery period associat‐
ed with  repeat  surgery,  and often prevents  the  need for  surgical  intervention.  Epidural
adhesiolysis was given an evidence rating of strong correlating to a 1B or 1C evidence level for
post–lumbar surgery syndrome in the most recent American Society of Interventional Pain
Physicians evidence-based guidelines. The therapy is supported by observational studies and
case series along with randomized-control trials. The recommendation was also made that this
therapy could apply to most patients with post laminectomy syndrome or failed back syn‐
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drome in many circumstances with informed consent [4]. Additionally, current procedural
terminology (CPT) codes have been assigned to the two different kinds of adhesiolysis: CPT
62263 for the three-times injections over 2 to 3 days, which has recently changed to 3 injec‐
tions 6- 8 hours apart within 24 hours, usually done in an inpatient hospital setting, and CPT
62264 for the one-time injection series surgery-center model that may need to be repeated 3 to
3.5 times in a 12-month period.
2. Pathophysiology of epidural fibrosis (scar tissue) as a cause of low back
pain with radiculopathy
The etiology of chronic low back pain with radiculopathy after appropriate surgery is not well
understood. Kuslich et al [5] addressed this issue when they studied 193 patients who had
undergone lumbar spine operations given local anesthesic into the epidural space. It was
postulated that sciatica could only be produced by stimulation of a swollen, stretched,
restricted (i.e., scarred) or compressed nerve root [5]. Back pain could be produced by
stimulation of several tissues, but the most common tissue of origin was the outer layer of the
annulus fibrosus and the posterior longitudinal ligament. Stimulation for pain generation of
the facet joint capsule rarely generated low back pain, and facet synovium and cartilage
surfaces of the facet or muscles were never tender [6].
The contribution of fibrosis to the etiology of low back pain has been debated [7–9]. There are
many possible etiologies of epidural fibrosis, including surgical trauma, an annular tear,
infection, hematoma, or intrathecal contrast material [10]. These etiologies have been well
documented in the literature. LaRocca and Macnab [11] demonstrated the invasion of fibrous
connective tissue into postoperative hematoma as a cause of epidural fibrosis, and Cooper et
al [12] reported periradicular fibrosis and vascular abnormalities occurring with herniated
intervertebral disks. McCarron et al [13] investigated the irritative effect of nucleus pulposus
on the dural sac, adjacent nerve roots, and nerve root sleeves independent of the influence of
direct compression on these structures. Evidence of an inflammatory reaction was identified
by gross inspection and microscopic analysis of spinal cord sections after homogenized
autogenous nucleus pulposus was injected into the lumbar epidural space of four dogs. In the
control group consisting of four dogs injected with normal saline, the spinal cord sections were
grossly normal. Parke and Watanabe [14] showed significant evidence of adhesions in cadavers
with lumbar disk herniation.
It is widely accepted that postoperative scar renders the nerve susceptible to injury by a
compressive phenomena [9]. It is natural for connective tissue or any kind of scar tissue to
form fibrous layers (scar tissue) as a part of the process that transpires after disruption of the
intact milieu [15]. Scar tissue is generally found in three components of the epidural space.
Dorsal epidural scar tissue is formed by reabsorption of surgical hematoma and may be
involved in pain generation [16]. In the ventral epidural space, dense scar tissue is formed by
ventral defects in the disk, which may persist despite surgical treatment and continue to
produce low back pain and radiculopathy past the surgical healing phase [17]. The lateral
epidural space includes the epiradicular structures outside the root canals, known as the lateral
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recesses or “sleeves,” which are susceptible to lateral disk defects, facet hypertrophy, and
neuroforaminal stenosis [18].
Although scar tissue itself is not tender, an entrapped nerve root is. Kuslich et al [5] surmised
that the presence of scar tissue compounded the pain associated with the nerve root by fixing
it in one position and thus increasing the susceptibility of the nerve root to tension or com‐
pression. They also concluded that no other tissues in the spine are capable of producing leg
pain. In a study of the relationship between peridural scar evaluated by magnetic resonance
imaging (MRI) and radicular pain after lumbar diskectomy, Ross et al [19] demonstrated that
subjects with extensive peridural scarring were 3.2 times more likely to experience recurrent
radicular pain.
This evidence also parallels a new study by Gilbert et al [20] in which lumbosacral nerve roots
were identified as undergoing less strain than previously published during straight leg raise
and in which hip motion greater than 60 degrees was determined to cause displacement of the
nerve root in the lateral recess.
3. Fluid foraminotomy: Foraminal adhesiolysis or disentrapment
Relative or functional foraminal root entrapment syndrome secondary to epidural fibrosis with
corresponding nerve root entrapment is frequently evident after an epidurogram and signified
by lack of epidural contrast flow into epidural finger projections at those levels. The lysis
procedure effectively serves as a fluid foraminotomy reducing foraminal stenosis caused by
epidural fibrosis. In addition to increasing foraminal cross-sectional area, adhesiolysis serves
to decompress distended epidural venous structures that may exert compression at nearby
spinal levels (Figures 1 and 2) and inevitably cause needle stick related epidural hematomas.
Adhesiolysis has led to the development of flexible epiduroscopy that is being pioneered by,
primarily initiated, pursued and to this day supported by Dr. James Heavner [21,22].
Figure 1. Engorged blood vessels in the epidural cavity as observed during epiduroscopy. Insert in upper right corner
is fluoroscopy showing location for epiduroscopy tip (left anterior border of L5).
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Figure 2. Engorged blood vessels in the epidural cavity in cadaver. See vein on right side next to the nerve root target
site for fluid foraminotomy and opening venous run off and decompression.
4. Diagnosis and radiologic diagnosis of epidural fibrosis
As with any patient, a thorough musculoskeletal and neurologic examination should be
performed. In addition to standard dural tension provocative tests, we recommend a provo‐
cative test called ‘dural tug.’ To perform the test, the patient should be instructed to sit up with
a straight leg, bend forward flexing the lumbar spine until their back pain starts to become
evident, and the head and neck flexed rapidly forward. During this maneuver, the dura is
stretched cephalad and if adhered to structures such as the posterior longitudinal ligament,
the most heavily innervated spinal canal structure, the movement of the dura will elicit back
pain that is localized to the pain generator. A positive dural tug maneuver has been observed
to resolve after percutaneous neuroplasty. (Figures 3-7).
Pain and Treatment292
Figure 3. The ‘dural tug’ maneuver being performed prior to percutaneous neuroplasty.
Figure 4. Note pain reproduction prior to full neck flexion secondary to dural adhesions.
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Figure 5. Patient after percutaneous neuroplasty with pain free neck and back flexion due to treatment of dural adhe‐
sions.
Figure 6. There is decreased spine flexion prior to treatment secondary to dural adhesions. The pain generator was
subsequently documented to be T9-T10 dural adhesion from an annular tear.
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Figure 7. After treatment, the same patient demonstrates increased painless flexion of the spine.
MRI and computed tomography (CT) are diagnostic tools; sensitivity and specificity are 50%
and 70%, respectively [15]. CT myelography may also be helpful, although none of the
aforementioned modalities can identify epidural fibrosis with 100% reliability. In contrast,
epidurography is a technique used with considerable success and it is believed that epidural
fibrosis is best diagnosed by performing an epidurogram [23–26]. It can detect filling defects
in good correlation with a patient's symptoms in real time [26]. A combination of several of
these techniques would undoubtedly increase the ability to identify epidural fibrosis.
4.1. current procedural terminology or CPT codes
The American Medical Association has developed Current Procedural Terminology codes for
epidural adhesiolysis, which include 62264 for a single infusion and 62263 for a staged three-
series infusion.
4.2. Indications for epidural adhesiolysis
Although originally designed to treat radiculopathy secondary to epidural fibrosis following
surgery, the use of epidural adhesiolysis has been expanded to treat a multitude of pain
etiologies. These include the following [27]:
1. Failed back surgery syndrome
2. Postlaminectomy syndrome of the neck and back after surgery
3. Disk disruption
4. Metastatic carcinoma of the spine leading to compression fracture
5. Multilevel degenerative arthritis
6. Facet pain
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7. Spinal stenosis
8. Pain unresponsive to spinal cord stimulation and spinal opioids
9. Thoracic disk related chest wall and abdominal pain (after mapping)
4.3. Contraindications
The following are absolute contraindications for performing epidural adhesiolysis:
1. Sepsis
2. Chronic infection
3. Coagulopathy
4. Local infection at the procedure site
5. Patient refusal
6. Syrinx formation
A relative contraindication is the presence of arachnoiditis. With arachnoiditis, the tissue
planes may be adherent to one another, increasing the chance of loculation of contrast or
medication. It may also increase the chance of spread of the medications to the subdural or
subarachnoid space, which can increase the chance of complications. Practitioners with limited
experience with epidural adhesiolysis should consider referring these patients to a clinician
with more training and experience.
5. Patient preparation
When epidural adhesiolysis has been deemed an appropriate treatment modality, the risks
and benefits of the procedure should be discussed with the patient and informed consent
obtained. The benefits are pain relief, improved physical function, and possible reversal of
neurologic symptoms. Risks include, but are not limited to, bruising, bleeding, infection,
reaction to medications used (i.e., hyaluronidase, local anesthetic, corticosteroids, hypertonic
saline), damage to nerves or blood vessels, no or little pain relief, bowel/bladder incontinence,
worsening of pain, and paralysis. Patients with a history of urinary incontinence should have
an urodynamic evaluation by a urologist before the procedure to document the preexisting
urodynamic etiology and pathology.
6. Anticoagulant medication
Medications that prolong bleeding and clotting parameters should be withheld before
performing epidural adhesiolysis. The length of time varies depending on the medication
taken. A consultation with the patient's primary physician should be obtained before stopping
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any of these medications, particularly in patients who require chronic anticoagulation such as
those with drug-eluting heart stents or prosthetic heart valves. Nonsteroidal anti-inflamma‐
tory drugs and aspirin, respectively, should be withheld 4 days and 7 to 10 days before the
procedure. Although there is much debate regarding these medications and neuraxial
procedures, we tend to be on the conservative side. Clopidogrel (Plavix) should be stopped 7
days before, whereas ticlopidine (Ticlid) is withheld 10 to 14 days before the adhesiolysis [28].
Warfarin (Coumadin) stoppage is variable but 5 days is usually adequate [27]. Patients on
subcutaneous heparin should have it withheld a minimum of 12 hours before the procedure,
whereas those on low-molecular-weight heparin require a minimum of 24 hours [28]. Over-
the-counter homeopathic medications that prolong bleeding parameters should also be
withheld. These include fish oil, vitamin E, gingko biloba, garlic, ginseng, and St. John's Wort.
Adequate coagulation status can be confirmed by the history, INR, prothrombin time, partial
thromboplastin time, and a platelet function assay or bleeding time. The tests should be
performed as close to the day of the procedure as possible. Tests performed only a few days
after stopping the anticoagulant medication may come back elevated because not enough time
has elapsed to allow the anticoagulant effects of the medication to resolve. The benefits of the
procedure must be weighed against the potential sequelae of stopping the anticoagulant
medication and this should be discussed thoroughly with the patient.
7. Preoperative laboratory
Before the procedure, a complete blood count and a clean-catch urinalysis are obtained to check
for any undiagnosed infections. An elevated white count and/or a positive urinalysis should
prompt the physician to postpone the procedure and refer the patient to the primary care
physician for further workup and treatment. In addition, history of bleeding, abnormalities a
prothrombin time, partial thromboplastin time, and platelet function assay or bleeding time,
are obtained to check for coagulation abnormalities. Any elevated value warrants further
investigation and postponement of the procedure until those studies are complete.
8. Technique
This procedure can be performed in the cervical, thoracic, lumbar, and caudal regions of the
spine. The caudal and transforaminal placement of catheters will be described in detail,
whereas highlights and slight changes in protocol will be provided for cervical and thoracic
catheters. Our policy is to perform this procedure under strict sterile conditions in the
operating room. Prophylactic antibiotics with broad neuraxial coverage are given before the
procedure. Patients will receive either ceftriaxone 1 g intravenously or Levaquin 500 mg orally
in those allergic to penicillin. The same dose is also given on day 2. An anesthesiologist or
nurse anesthetist provides monitored anesthesia care.
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9. Caudal approach
The patient is placed in the prone position with a pillow placed under the abdomen to correct
the lumbar lordosis and a pillow under the ankles for patient comfort. The patient is asked to
put his or her toes together and heels apart. This relaxes the gluteal muscles and facilitates
identification of the sacral hiatus. After sterile preparation and draping, the sacral hiatus is
identified via palpation just caudal to the sacral cornu or with fluoroscopic guidance. A skin
wheal is raised with local anesthetic 1-inch lateral and 2 inches caudal to the sacral hiatus on
the side opposite the documented radiculopathy. A distal subcutaneous approach theoretically
provides some protection from meningitis, as a local skin infection would be much preferred
over infection closer to the caudal epidural space. The skin is nicked with an 18-gauge cutting
needle, and a 15-or 16-gauge RX Coudé (Epimed International) epidural needle is inserted
through the nick at a 45-degree angle and guided fluoroscopically or by palpation to the sacral
hiatus (Figures 8 and 9).
Figure 8. Caudal lysis sequence—first find sacral hiatus and tip of coccyx.
When the needle is through the hiatus, the angle of the needle is dropped to approximately 30
degrees and advanced. The advantages of the RX Coudé needle over other needles are the
angled tip, which enables easier direction of the catheter, and the tip of the needle is less sharp.
The back edge of the distal opening of the needle is designed to be a noncutting surface that
allows manipulation of the catheter in and out of the needle. A Touhy needle has the back edge
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of the distal opening, which is a cutting surface and can more easily shear a catheter. A properly
placed needle will be inside the caudal canal below the level of the S3 foramen on anteropos‐
terior (AP) and later fluoroscopic images. A needle placed above the level of the S3 foramen
could potentially puncture a low-lying dura. The needle tip should cross the midline of the
sacrum toward the side of the radiculopathy.
Figure 9. Roll palpating index finger to identify the sacral cornu and thus the target sacral hiatus.
An epidurogram is performed using 10 mL of a non-ionic, water-soluble contrast agent.
Confirm a negative aspiration for blood or cerebrospinal fluid before any injection of the
contrast or medication. Omnipaque and Isovue are the two agents most frequently used and
are suitable for myelography [29, 30]. Do not use ionic, water-insoluble agents such as
Hypopaque or Renografin or ionic, water-soluble agents such as Conray [31,32]. These agents
are not indicated for myelography. Accidental subarachnoid injections can lead to serious
untoward events such as seizure and possibly death. Slowly inject the contrast agent and
observe for filling defects. A normal epidurogram will have a “Christmas tree” pattern with
the central canal being the trunk and the outline of the nerve roots making up the branches.
An abnormal epidurogram will have areas where the contrast does not fill (Figure 10). These
are the areas of presumed scarring and typically correspond to the patient's radicular com‐
plaints. If vascular uptake is observed, the needle needs to be redirected.
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Figure 10. Initial dye injection Omnipaque 240 (10 mL) showing sacral S3 runoff and filling defects at S2, S1, and right L5.
After turning the distal opening of the needle ventral lateral, insert a TunL Kath or TunL-XL
(stiffer) catheter (Epimed International) with a bend on the distal tip through the needle
(Figures 11 and 12). The bend should be 2.5 cm from the tip of the catheter and at a 30-degree
angle. The bend will enable the catheter to be steered to the target level (Figure 13). Under
continuous AP fluoroscopic guidance, advance the tip of the catheter toward the ventral-lateral
epidural space of the desired level. The catheter can be steered by gently twisting the catheter
in a clockwise or counterclockwise direction. Avoid “propellering” the tip (i.e., twisting the
tip in circles) because this makes it more difficult to direct the catheter. Do not advance the
catheter up the middle of the sacrum because this makes guiding the catheter to the ventral-
lateral epidural space more difficult. Ideal location of the tip of the catheter in the AP projection
is in the foramen just below the midportion of the pedicle shadow (Figures 14 and 15). Check
a lateral projection to confirm that the catheter tip is in the ventral epidural space.
Figure 11. The needle is placed through the sacral hiatus into the sacral canal and rotated in the direction of the target.
Do not advance beyond the S3 foramen.
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Figure 12. The Epimed Racz catheter is marked for the location of the bend, or use the thumb as reference for the 15-
degree angle bend.
Figure 13. The direction of the catheter is just near the midline; direct the curve under continuous fluoroscopic guid‐
ance to the ventral lateral target site. The needle rotation, as well as the catheter navigation, may need to be used to
reach the target.
Epidural Lysis of Adhesions and Percutaneous Neuroplasty
http://dx.doi.org/10.5772/58753
301
Figure 14. The needle is removed, and the catheter is placed in the ventral lateral epidural space ventral to the nerve
root.
Figure 15. Catheter (24xL) is threaded to lateral L5 neural foramen.
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Under real-time fluoroscopy, inject 2 to 3 mL of additional contrast through the catheter in an
attempt to outline the “scarred in” nerve root (Figure 16). If vascular uptake is noted, reposition
the catheter and reinject contrast. Preferably there should not be vascular runoff, but infre‐
quently secondary to venous congestion, an epidural pattern is seen with a small amount of
vascular spread. This is acceptable as long as the vascular uptake is venous in nature and not
arterial. Extra caution should be taken when injecting the local anesthetic to prevent local
anesthetic toxicity. Toxicity is volume and dose related and so far there has not been any
reported complications from small volume venous spread. Any arterial spread of contrast
always warrants repositioning of the catheter. We have never observed intra-arterial place‐
ment in 25 years of placing soft, spring-tipped catheters.
Figure 16. Contrast injection Omnipaque 240, additional 5 mL opening right L5, S1, S2, and S3 perineural spaces; also
left L5, S1, S2, and S3 in addition to right L4 spread in cephalad direction.
Inject 1500 U of hyaluronidase dissolved in 10 mL of preservative-free normal saline. A newer
development is the use of Hylenex or human-recombinant hyaluronidase, which carries the
advantage of a reportedly increased effectiveness at the body's normal pH compared to bovine-
recombinant hyaluronidase [33]. This injection may cause some discomfort, so a slow injection
is preferable. Observe for “opening up”(i.e. visualization) of the “scarred in” nerve root
(Figures 17 and 18 see also Figure 16). A 3 mL test dose of a 10 mL local anesthetic/steroid (LA/
S) solution is then given. Our institution used 4 mg of dexamethasone mixed with 9 mL of 0.2%
ropivacaine. Ropivacaine is used instead of bupivacaine for two reasons: the former produces
a preferential sensory versus a motor block, and it is less cardiotoxic than a racemic bupiva‐
caine. Doses for other corticosteroids commonly used are 40 to 80 mg of methylprednisolone
(Depo-Medrol), 25 to 50 mg of triamcinolone diacetate (Aristocort), 40 to 80 mg of triamcino‐
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lone acetonide (Kenalog), and 6 to 12 mg of betamethasone (Celestone Solu span). If, after 5
minutes, there is no evidence of intrathecal or intravascular injection of medication, inject the
remaining 7 mL of the LA/S solution.
Figure 17. Additional contrast and hyaluronidase injection opens up bilaterally formerly scarred areas. The Christmas
tree appearance is obvious.
Figure 18. Catheter advances to the desired symptomatic level of right L5 in the ventral lateral epidural space. Injection
of contrast followed by 10 mL hyaluronidase 1,500 units opens up bilaterally L3-5, S1, S2, and S3 neural foramina.
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Remove the needle under continuous fluoroscopic guidance to ensure the catheter remains at
the target level (Figure 19). Secure the catheter to the skin using nonabsorbable suture and coat
the skin puncture site with antimicrobial ointment. Apply a sterile dressing and attach a 0.2
μ m filter to the end of the catheter. Affix the exposed portion of the catheter to the patient
with tape and transport the patient to the recovery area.
Figure 19. Five picture sequence of removal of the needle to prevent dislodging the catheter from target site before
suturing and application of dressing.
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A 20-to 30-minute period should elapse between the last injection of the LA/S solution and the
start of the hypertonic saline (10%) infusion. This is necessary to ensure that a subdural
injection of the LA/S solution has not occurred. A subdural block mimics a subarachnoid block
but it takes longer to establish, usually 16 to 18 minutes. Evidence for subdural or subarachnoid
spread is the development of motor block. If the patient develops a subarachnoid or subdural
block at any point during the procedure, the catheter should be removed and the remainder
of the adhesiolysis canceled. The patient needs to be observed to document the resolution of
the motor and sensory block and to document that 10 mL of the hypertonic saline is then
infused through the catheter over 15 to 30 minutes. If the patient complains of discomfort, the
infusion is stopped and an additional 2 to 3 mL of 0.2% ropivacaine is injected and the infusion
is restarted. Alternatively, 50 to 75 μ g of fentanyl can be injected epidurally in lieu of the local
anesthetic. After completion of the hypertonic saline infusion, the catheter is slowly flushed
with 2 mL of preservative-free normal saline and the catheter is capped.
Our policy is to admit the patient for 24-hour observation status and do a second and a third
hypertonic saline infusion the following day. On post–catheter insertion day 2, the catheter is
twice injected (separated by 4-to 6-hour increments) with 10 mL of 0.2% ropivacaine without
steroid and infused with 10 mL of hypertonic saline (10%) using the same technique and
precautions as the day 1 infusion. At the end of the third infusion, the catheter is removed and
a sterile dressing applied. The patient is discharged home with 5 days of oral cephalexin at 500
mg twice a day or oral levofloxacin (Levaquin) at 500 mg once a day for penicillin-allergic
patients. Clinic follow-up is in 30 days.
10. Transforaminal catheters
Patients with an additional level of radiculopathy or those in whom the target level cannot be
reached by the caudal approach may require placement of a second catheter. The second
catheter is placed into the ventral epidural space via a transforaminal approach.
After the target level is identified with an AP fluoroscopic image, the superior endplate of the
vertebra that comprises the caudal portion of the foramina is “squared,” that is, the anterior
and posterior shadows of the vertebral endplate are superimposed. The angle is typically 15
to 20 degrees in a caudocephalad direction. The fluoroscope is then oblique approximately 15
degrees to the side of the radiculopathy and adjusted until the spinous process is rotated to
the opposite side. This fluoroscope positioning allows the best visualization of the superior
articular process (SAP) that forms the inferoposterior portion of the targeted foramen. The
image of the SAP should be superimposed on the shadow of the disk space on the oblique
view. The tip of the SAP is the target for the needle placement (Figure 20). Raise a skin wheal
slightly lateral to the shadow of the tip of the SAP. Pierce the skin with an 18-gauge needle
and then insert a 15-or 16-gauge RX Coudé needle and advance using gun-barrel technique
toward the tip of the SAP. Continue to advance the needle medially toward the SAP until the
tip contacts bone. Rotate the tip of the needle 180 degrees laterally and advance about 5 mm
(Figure 21). Rotate the needle back medially 180 degrees (Figure 22).
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Figure 20. Transforaminal lateral-oblique view. Target the SAP with the advancing RX Coude needle.
Figure 21. Following bony contact with SAP. Lateral rotation of 180 degrees to allow passage toward the target.
Figure 22. Note the intertransverse ligament. The needle tip with the RX Coude 2 that has 1 mm protruding blunt
stylet will pass through the ligament and will be less likely to damage the nerve.
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As the needle is advanced slowly, a clear “pop” is felt as the needle penetrates the intertrans‐
verse ligament. Obtain a lateral fluoroscopic image. The tip of the needle should be just past
the SAP in the posterior foramen. In the AP plane, the tip of the needle under continuous AP
fluoroscopy, insert the catheter slowly into the foramen and advance until the tip should be
just short of the middle of the spinal canal (Fig 23-25).
Figure 23. The distal tip of the catheter may be bent 15-degrees, 3/4 inch length.
Figure 24. Once the intertransverse ligament is perforated, the catheter is steered to the ventral lateral epidural space
(lateral view).
Confirm that the catheter is in the anterior epidural space with a lateral image (Figure 26).
Anatomically, the catheter is in the foramen above or below the exiting nerve root (Figure
27). If the catheter cannot be advanced, it usually means the needle is either too posterior or
too lateral to the foramen. It can also indicate that the foramen is too stenotic to allow passage
of the catheter. The needle can be advanced a few millimeters anteriorly in relation to the
foramen, and that will also move it slightly medial into the foramen. If the catheter still will
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not pass, the initial insertion of the needle will need to be more lateral. Therefore the fluoro‐
scope angle will be about 20 degrees instead of 15 degrees. The curve of the needle usually
facilitates easy catheter placement. The final position of the catheter tip is just short of the
midline.
Figure 26. Lateral view of Figure. 16-13. Transforaminal-ventral-anterior catheter dye spread to epidural and L3-4 in‐
tradiscal area (through annular tear).
Figure 25. Transforaminal 15-gauge RX-Coude 2 (Epimed International, Johnstown, NY) catheter at left L3-4 threaded
almost to near midcanal position (anteroposterior view).
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Figure 27. Anteroposterior view. The catheter is in optimal position near midline via the transforaminal placement.
Inject 1 to 2 mL of contrast to confirm epidural spread. When a caudal and a transforaminal
catheter are placed, the 1500 U of hyaluronidase are divided evenly between the two catheters
(5 mL of the hyaluronidase/saline solution into each). The LA/S solution is also divided evenly,
but a volume of 15 mL (1 mL steroid and 14 mL 0.2% ropivacaine; of the total volume, 5 mL is
transforaminal and 10 mL is caudal) is used instead of 10 mL. Remove the needle under
fluoroscopic guidance to make sure the catheter does not move from the original position in
the epidural space. Secure and cover the catheter as described previously. The hypertonic
saline solution is infused at a volume of 4 to 5 mL per transforaminal and 8 to 10 mL per caudal
catheter over 30 minutes. The hypertonic saline injection volume should always be less than
or equal to the local anesthetic volume injected to avoid pain from injection. It behooves the
practitioner to check the position of the transforaminal catheter under fluoroscopy before
performing the second and third infusions. The catheter may advance across the epidural space
into the contralateral foramen or paraspinous muscles or more commonly back out of the
epidural space into the ipsilateral paraspinous muscles.
This results in deposition of the medication in the paravertebral tissue rather than in the
epidural space. As with the caudal approach, remove the transforaminal catheter after the third
infusion. A recent development is the R-X Coude 2 needle in which a second protruding stylet
may allow closer needle placement and less chance of nerve injury.
11. 1st sacral foramen approach
The area at the L5S1 anterolateral epidural space is frequently occupied with epidural
adhesions which are associated with pain and a lack of contrast filling on epidurography. This
volume of this space has been measured to be 1.1 ml anatomically and 0.9 ml surgically [34].
Lysis of adhesions via the caudal approach may be difficult in patients with epidural adhesions
at this location and the S1 foraminal approach may be used to achieve lysis and fluid fora‐
minotomy at this level [35].
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Matsumoto reported 36 cases with adhesive S-1 radiculopathy. After the procedure, the
patients were followed up for 12 months. A marked decrease in VAS and improvement in ADL
(improvement in ODI scores) were observed [36].
http://www.paincast.com has video information regarding this procedure [37].
12. Cervical lysis of adhesions
The success of the caudal approach for lysis of adhesions led to the application of the same
technique to the cervical epidural space. The indications and preprocedure workup are the
same as those for the caudal lysis technique, but there are a few differences in technique and
volumes of medication used.
The epidural space should be entered via the upper thoracic interspaces using a paramedian
approach on the contralateral side. The most common levels are T1-2 and T2-3. Entry at these
levels allows for a sufficient length of the catheter to remain in the epidural space after the
target level has been reached. If the target is the lower cervical nerve roots, a more caudal
interspace should be selected. We place the patient in the left lateral decubitus position, but
use a prone approach in larger patients.
A technique referred to as the “3-D technique” is used to facilitate entry into the epidural space.
The “3-D” stands for direction, depth, and direction. Using an AP fluoroscopic image, the initial
direction of the 15-or 16-gauge RX Coudé needle is determined. Using a modified paramedian
approach with the skin entry one and a half levels below the target interlaminar space, advance
and direct the needle toward the midpoint of the chosen interlaminar space with the opening
of the needle pointing medial. Once the needle engages the deeper tissue planes (usually at 2
to 3 cm), check the depth of the needle with a lateral image. Advance the needle toward the
epidural space and check repeat images to confirm the depth. The posterior border of the dorsal
epidural space can be visualized by identifying the junction of the base of the spinous process
of the vertebra with its lamina. This junction creates a distinct radiopaque “straight line.” Once
the needle is close to the epidural space, obtain an AP fluoroscopic image to recheck the
direction of the needle. If the tip of the needle has crossed the midline as defined by the spinous
processes of the vertebral bodies, pull the needle back and redirect. The “3-D” process can be
repeated as many times as is necessary to get the needle into the perfect position.
Using loss-of-resistance technique, advance the needle into the epidural space with the tip of
the RX-Coudé needle, pointed caudally. Once the tip is in the epidural space, rotate the tip
cephalad, and inject 1 to 2 mL of contrast to confirm entry. Rotation or movement of any needle
in the epidural space can cut the dura. This technique has been improved with the advent of
the RX Coudé 2 needle, which has a second interlocking stylet that protrudes slightly beyond
the tip of the needle and functions to push the dura away from the needle tip as it is turned
180 degrees cephalad (Figures 28-32).
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Figure 28. Sequence of stages to place a catheter using the R-X Coude, part 1: The needle is inserted into the epidural
space with the tip directed as shown.
Figure 29. Sequence of stages to place a catheter using the R-X Coude, part 2: The needle is inserted into the epidural
space with the tip directed as shown.
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Figure 30. Sequence of stages to place a catheter using the R-X Coude, part 3: The protruding stylet is inserted.
Figure 31. Sequence of stages to place a catheter using the R-X Coude, part 4: Then the needle is rotated so the tip is
parallel to the dura.
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Figure 32. Sequence of stages to place a catheter using the R-X Coude, part 5: The catheter is inserted.
Inject an additional small volume as needed to complete the epidurogram. If there is no free
flow of injected contrast, pressure may build up in the lateral epidural space. Characteristic
fluid spread by the path of least resistance can be recognized as perivenous counter spread
(PVCS). Presence of PVCS means pressure builds up in the lateral epidural space that is unable
to spread laterally to decompress. The dye spread picks the path of least resistance to the
opposite side. Pressure may build up and lead to ischemic spinal cord injury. Flexion and
rotation of the head and neck can open up lateral runoff and release the pressure through the
enlarged neural foramina (Figure 33) [38].
As with the caudal epidurogram, look for filling defects. It is extremely important to visualize
spread of the contrast in the cephalad and caudal directions. Loculation of contrast in a small
area must be avoided as this can significantly increase the pressure in the epidural space and
can compromise the already tenuous arterial blood supply to the spinal cord. Place a bend on
the catheter as previously described for the caudal approach and insert it through the needle
(Figure 32). The opening of the needle should be directed toward the target side. Slowly advance
the catheter to the lateral gutter and direct it cephalad. Redirect the catheter as needed and once
the target level has been reached, turn the tip of the catheter toward the foramen (Figure 34).
Inject 0.5 to 1 mL of contrast to visualize the target nerve root. Make sure there is runoff of
contrast out of the foramen (Figure 35). Slowly instill 150 U of Hylenex dissolved in 5 mL of
preservative-free normal saline. Follow this with 1 to 2 mL of additional contrast and observe
for “opening up” of the “scarred in” nerve root. Give a 2 mL test dose of a 6 mL solution of LA/
S. Our combination is 5 mL of 0.2% ropivicaine and 4 mg of dexamethasone. If after 5 minutes
there is no evidence of intrathecal or intravascular spread, inject the remaining 4 mL. Remove
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the needle, and secure and dress the catheter as previously described. Once 20 minutes have
passed since the last dose of LA/S solution and there is no evidence of a subarachnoid or subdural
block, start an infusion of 5 mL of hypertonic saline over 30 minutes. At the end of the infu‐
sion, flush the catheter with 1 to 2 mL of preservative-free normal saline and cap the catheter.
Figure 34. Cervical left ventral lateral catheter to the upper level of fusion C5-7.
Figure 33. Flexion rotation, left to right regardless patient position. The neural foramen enlarges on flexion rotation
and gets smaller with extension. The inferior pars slides forward over the superior pars to enlarge the foramen. This
allows lateral run off and pressure release with PVCS.
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Figure 35. Cervical-left ventral lateral catheter threaded to above level of fusion of C4. The dye injection spreads cepha‐
lad and lateral.
The second and third infusions are performed on the next day with 6 mL of 0.2% ropivacaine
without spread and 5 mL of hypertonic saline using the same technique and precautions
described for the first infusion. The catheter is removed and prophylactic antibiotics are
prescribed. Clinic follow-up is 30 days.
13. Thoracic lysis of adhesions
The technique for entry into the thoracic epidural space for adhesiolysis is identical to that for
the cervical region. Always remember the 3-D technique. Make sure to get a true lateral when
checking the depth of the needle. This can be obtained by superimposing the rib shadows on
one another. The target is still the ventrolateral epidural space with the tip of the catheter in
the foramen of the desired level. The major difference for thoracic lysis compared to the caudal
and cervical techniques is the volumes of the various injectates. Volumes of 8 mL are used for
the contrast, Hylenex, LA/S, and hypertonic saline. Table 1 lists typical infusion volumes for
epidural adhesiolysis.
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Contrast Hyaluronidase andNormal Saline
Local Anesthetic and
Steriod
10% Hypertonic Saline
Infusion
Caudal 10 mL 10 mL 10 mL 10 mL
Caudal and
transforaminal 5 mL in each catheter 5 mL in each catheter 5 mL in each catheter
8 mL in caudal catheter
and 4 mL in
transforaminal catheter
Thoracic 8 mL 8 mL 8 mL 8 mL
Cervical 5 mL 6 mL 6 mL 5 mL
Table 1. Typical Infusion Volumes for Epidural Adhesiolysis
14. Neural flossing
The protocol for epidural adhesiolysis has been aided by neural flossing exercises that were
designed to mobilize nerve roots by “sliding” them in and out of the foramen (Figure 36). This
breaks up weakened scar tissue from the procedure and prevents further scar tissue deposition.
If these exercises are done effectively three to four times per day for a few months after the
procedure, the formation of scar tissue will be severely restricted.
Figure 36. Neural flossing exercises, part 1: Standing erect, firmly grasp a stable surface (e.g., a door frame) with out‐
stretched arm. Press elbow and shoulder forward.
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Figure 37. Neural flossing exercises, part 2: Next, slowly tilt head in opposite direction from outstretched arm to ach‐
ieve gentle tension.
Figure 38. Neural flossing exercises, part 3: Finally, rotate chin toward opposite shoulder as is comfortable. Hold this
final position for approximately 20 to 30 seconds.
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Figure 39. Neural flossing exercises, part 4: Lay down supine on an exercise mat without a pillow. Slowly bring both
knees close to the chest with bent legs and hold this position for 20 seconds. Release and assume a neutral position.
Figure 40. Neural flossing exercises, part 5: Again in supine position, raise both legs to 90 degrees, with knees straight
while laying flat on a firm surface. Hold for 20 seconds. Assume a neutral position and rest briefly.
Figure 41. Neural flossing exercises, part 6: Bring both legs to a 90-degree angle while lying supine. Slowly spread legs
in a V shape, as much as is comfortable, and hold for 20 seconds.
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15. Epidural mapping
In patients with multilevel radiculopathy and complex pain, it can be difficult to determine
from where the majority of the pain is emanating. We have been using a technique that we
have termed mapping to locate the most painful nerve root with stimulation and then carry out
the adhesiolysis at that level. There are several references in the literature regarding the use of
stimulation to confirm epidural placement of a catheter and for nerve root localization [39].
The TunL Kath and the TunL-XL catheter can be used as stimulating catheters to identify the
nerve root(s).
After entering the epidural space, advance the catheter into the ventrolateral epidural space
past the suspected target level. Make sure the tip of the catheter is pointing laterally toward
the foramina, just below the pedicle. Pull the catheter stylet back approximately 1 cm. Using
alligator clips, attach the cathode to the stylet and ground the anode on the needle or ground
pad or a 22-gauge needle inserted into the skin. Apply electrical stimulation with a stimulator
box with a rate of 50 pulses per second and a pulse width of 450 milliseconds, dialing up the
amplitude until a paresthesia is perceived in small increments, usually less than 2 or 3 volts.
Inquire of the patient as to whether or not the paresthesia is felt in the area of the patient's
recognized greatest pain. This process is repeated at each successive level until the most painful
nerve root is identified. Once identified, the adhesiolysis is carried out at that level. The
mapping procedure is also useful to identify the optimal site of surgery either before the first
surgery or when surgery has failed one or more times.
16. Complications
As with any invasive procedure, complications are possible. These include bleeding, infection,
headache, damage to nerves or blood vessels, catheter shearing, bowel/bladder dysfunction,
paralysis, spinal cord compression from loculation of the injected fluids or hematoma,
subdural or subarachnoid injection of local anesthetic or hypertonic saline, and reactions to
the medications used. We also include on the consent form that the patient may experience an
increase in pain or no pain relief at all.
Although the potential list of complications is long, the frequency of complications is very rare.
However, there is clearly a learning curve, and recent studies reflect this by the significantly
improved long-term outcome and the very rare publications of complications and medicolegal
consequences when one considers the ever-increasing clinical experience.
Subdural spread is a complication that should always be watched for when injecting local
anesthetic. During the caudal adhesiolysis, particularly if the catheter is advanced along the
midline, subdural catheter placement is a risk (Figure 42 and 43). Identification of the subdural
motor block should occur within 16 to 18 minutes. Catheters used for adhesiolysis should never
be directed midline in the epidural space.
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Figure 42. Midline catheter placement enters subdural space. There is also some epidural dye spread. But the patient
starts to complain of bilateral leg pain.
Figure 43. A 22-gauge spinal needle and extension set with syringe placed in the subdural space and 12 mL fluid aspi‐
rated. The patient reported immediate reversal of bilateral leg pain. Note the dye in the extension tubing and syringe
at the 7-o'clock position.
Most hematomas and other major complications are associated with the use of sharp needles.
The use of blunt needles or catheters should be considered to reduce the risk of major com‐
plications with the lysis procedure or transforaminal procedures [40].
Venous run off is most common on the first epidural procedure due to high-pressure veins
being engorged and large. Following lysis of adhesions and fluid foraminotomy, these high-
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pressure veins are converted to low-pressure veins and venous run off is less likely. In fact, no
cases of hematoma have been reported after lysis of adhesions and fluid foraminotmy in the
ventrolateral epidural space [41].
A case of a hematoma has been reported after the MILD procedure before lysis was performed.
Lysis should be considered prior to the MILD procedure to achieve fluid foraminotomies and
allow fluid to pass out of the spinal canal and avoid venous run off and hematomas [42].
17. Outcomes
Initially in the early 1980s the protocol was designed to direct site-specific medication onto the
dorsal root ganglion; however, after performing a number of the procedures, it was found that
the dorsal root ganglion was exceptionally hard to reach secondary to developing scar tissue
or adhesions. In the early days, our understanding was coming from the use of local anesthet‐
ics for surgery giving a 2-to 4-hour block for the surgeon to operate. It was gratifying to see
chronic pain patients get months and years of pain relief following the placement of the new
steerable x-ray visible catheter. The early report in 1985 by Racz et al [43] described the use of
phenol at the dorsal root ganglion followed by an observational listing of outcomes that were
clearly not as good as the latest studies on failed back surgery and spinal stenosis showing 75%
to 80% improvement at 12 months' follow-up by Manchikanti [38]. Initially we were pleased to
see some patients getting 3 to 4 months of relief and report seeing recovery of footdrops. This
philosophy still proves to be true even in studies in 2008 by Sakai et al [44] in which they found
that adhesiolysis with catheter-directed steroid and local anesthetic injection during epiduro‐
scopy alleviated pain and reduced sensory nerve dysfunction in patients with chronic sciati‐
ca. The evolution of these findings has changed the process into what it is today [45]. Racz and
Holubec first reported on epidural adhesiolysis in 1989 [46]. There were slight variations in the
protocol compared to today's protocol, namely the dose of local anesthetic and the fact that
hyaluronidase was not used. Catheter placement was lesion-specific (i.e., the tip of the catheter
was placed in the foramen corresponding to the vertebral level and side of the suspected
adhesions). The retrospective analysis conducted 6 to 12 months after the procedure reported
initial pain relief in 72.2% of patients (N=72) at time of discharge. Relief was sustained in 37.5%
and 30.5% of patients at 1 and 3 months, respectively. Forty-three percent decreased their
frequency and dosage of medication use and 16.7% discontinued their medications altogeth‐
er. In total, 30.6% of patients returned to work or returned to daily functions. In April 1990, at
a presentation of the 7th IASP World Congress on Pain in Adelaide, Austraila, Arthur et al [47]
reported on epidural adhesiolysis in 100 patients, 50 of whom received hyaluronidase as part
of the procedure. In the hyaluronidase group, 81.6% of the participants had initial pain relief,
with 12.3% having persistent relief; 68% of the no hyaluronidase group had relief of pain, with
14% having persistent relief at the end of the 3-year follow-up period from which the study
sample was randomly selected.
An informal survey of ophthalmologic anesthesiologists found no cases of anaphylaxis to
hyaluronidase used for retrobulbar blocks. In this survey, skin testing for allergy to hyaluroni‐
dase was not reported. This implies that severe allergic reactions are rare; however, it is
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recommended that  these procedures be performed in an environment with resuscitative
equipment [48].
In 1994 Stolker et al [49] added hyaluronidase to the procedure, but omitted the hypertonic
saline. In a study of 28 patients, they reported greater than 50% pain reduction in 64% of
patients at 1 year. They stressed the importance of the patient selection and believed that the
effectiveness of adhesiolysis was based on the effect of the hyaluronidase on the adhesions
and the action of the local anesthetic and steroids on the sinuvertebral nerve.
Devulder et al published a study of 34 patients with failed back surgery syndrome in whom
epidural fibrosis was suspected or proved with MRI [50] and an epidural catheter was inserted
via the sacral hiatus to a distance of 10 cm into the caudal canal. Injections of contrast dye, local
anesthetic, corticosteroid, and hypertonic saline (10%) were carried out daily for 3 days. No
hyaluronidase was used. Filling defects were noted in 30 of 34 patients, but significant pain
relief was noted in only 7 patients at 1 month, 2 patients at 3 months, and no patients at 12
months. They concluded that epidurography may confirm epidural filling defects for contrast
dye in patients with filling defects, but a better contrast dye spread, assuming scar lysis does
not guarantee sustained pain relief. This study was criticized for lack of lesion-specific catheter
placement resulting in nonspecific drug delivery [51]. The catheter was never directed to the
ventral lateral epidural space where the dorsal root ganglion is located and the lateral recess
scarring occurs.
Heavner et al [52] performed a prospective randomized trial of lesion-specific epidural
adhesiolysis on 59 patients with chronic intractable low back pain. The patients were assigned
to one of four epidural adhesiolysis treatment groups: (1) hypertonic (10%) saline plus
hyaluronidase, (2) hypertonic saline, (3) isotonic (0.9%) saline, or (4) isotonic saline plus
hyaluronidase. All treatment groups received corticosteroid and local anesthetic. Overall,
across all four treatment groups, 83% of patients had significant pain relief at 1 month
compared to 49% at 3 months, 43% at 6 months, and 49% at 12 months. The hyaluronidase and
the hypertonic saline study group had a much lower incidence of additional need for pain
procedures than the placebo groups, showing that site-specific catheter placement is impor‐
tant. Active substances and preservative free normal saline were blinded for the placebo effect.
Manchikanti et al [53] performed a retrospective randomized evaluation of a modified Racz
adhesiolysis protocol in 232 patients with low back pain. The study involved lesion specific
catheter placement, but the usual 3-day procedure was reduced to a 2-day (group 1) or a 1-day
(group 2) procedure. Group 1 had 103 patients and group 2 had 129 patients. Other changes
included changing the local anesthetic from bupivacaine to lidocaine, substituting methyl‐
prednisolone acetate or betamethasone acetate and phosphate for triamcinolone diacetate, and
reduction of the volume of injectate. Of the patients in groups 1 and 2, 62% and 58% had greater
than 50% pain relief at 1 month, respectively, with these percentages decreasing to 22% and
11% at 3 months, 8% and 7% at 6 months, and 2% and 3% at 1 year. Of significant interest is
that the percentage of patients receiving greater than 50% pain relief after four procedures
increased to 79% and 90% at 1 month, 50% and 36% at 3 months, 29% and 19% at 6 months,
and 7% and 8% at 1 year for groups 1 and 2, respectively. Short-term relief of pain was
demonstrated, but long-term relief was not.
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Manchikanti, in 1999, evaluated two groups of randomly pulled, 150 patients for a 2-day
reinjection procedure, and a second 150 patients for a one-day procedure out of a pool of 536
patients. It was concluded that repeat use of the one-day procedure is also cost effective when
evaluated on a 12-month follow-up. The cost effectiveness indicated the lysis procedure to be
superior to surgery or the rehabilitation activity program [53].
In a randomized, prospective study, Manchikanti et al [54] evaluated a 1-day epidural
adhesiolysis procedure against a control group of patients who received conservative therapy.
Results showed that cumulative relief, defined as relief greater than 50% with one to three
injections, in the treatment group was 97% at 3 months, 93% at 6 months, and 47% at 1 year.
The study also showed that overall health status improved significantly in the adhesiolysis
group. Conservative therapy consisted of physical therapy and medications.
In 2004 Manchikanti et al [55] published their results of a randomized, double-blinded,
controlled study on the effectiveness of 1-day lumbar adhesiolysis and hypertonic saline
neurolysis in treatment of chronic low back pain. Seventy-five patients whose pain was
unresponsive to conservative modalities were randomized into one of three treatment groups.
Group 1 (control group) underwent catheterization where the catheter was in the sacral canal
without adhesiolysis, followed by injection of local anesthetic, normal saline, and steroid.
Group 2 consisted of catheterization with site-specific catheter placement being ventral-lateral
for adhesiolysis, followed by injection of local anesthetic, normal saline, and steroid. Group 3
consisted of site-specific catheter placement for adhesiolysis, followed by injection of local
anesthetic, hypertonic saline, and steroid. Patients were allowed to have additional injections
based on the response, either after unblinding or without unblinding after 3 months. Patients
without unblinding were offered either the assigned treatment or another treatment based on
their response. If the patients in group 1 or 2 received adhesiolysis and injection and injection
of hypertonic saline, they were considered withdrawn, and no subsequent data were collected.
Outcomes were assessed at 3, 6, and 12 months using visual analog scale pain scores, Oswestry
Disability Index, opioid intake, range-of-motion measurement, and P-3. Significant pain relief
was defined as average relief of 50% or greater. Seventy-two percent of patients in group 3,
60% of patients in group 2, and 0% of patients in group 1 showed significant pain relief at 12
months. The average number of treatments for 1 year was 2.76 in group 2 and 2.16 in group 3.
Duration of significant relief with the first procedure was 2.8+1.49 months and 3.8+3.37 months
in groups 2 and 3, respectively. Significant pain relief (>50%) was also associated with
improvement in Oswestry Disability Index, range of motion, and psychologic status.
Manchikanti et al [56, 57] furthered this research using comparisons of percutaneous adhe‐
siolysis versus fluoroscopically guided caudal epidural steroid injections. The first study
involved a population of patients with chronic low back pain and known spinal stenosis. The
results showed a 76% reduction in pain relief at 1 year with epidural adhesiolysis compared
to 4% in the control group. The second study performed in a population of patients with post–
lumbar surgery syndrome showed a reduction in pain and improvement in functional status
in 73% of the epidural adhesiolysis group compared to 12% in the control group.
In 2006 a study by Veihelmann et al [58] evaluated patients with a history of chronic low back
pain and sciatica. Inclusion criteria were radicular pain with a corresponding nerve root
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compressing substrate found on MRI or CT. All patients were randomized to receive physio‐
therapy, analgesics, or lysis of adhesions. The lysis group had statistically significantly better
outcome than the physical therapy treatment group.
Two other prospective evaluations by Chopra et al and Gerdesmeyer et al [59, 60] evaluated
patients with monosegmental radiculopathy of the lumbar spine. All the patients suffered from
chronic disk herniations or failed back syndrome. All these randomized trials showed positive
short-term and long-term relief. Two prospective evaluations also showed positive short-and
long-term relief [60, 61].
Gerdesmeyer has published a prospective double blind placebo controlled multicenter trial,
which has been the most significant evaluation of the technique. The target site remained
ventral lateral at the most likely level of the pain generator. The study continued for over 12
months and the significant finding was that the study arm of the procedure showed better
outcome at all points of measurements. The placebo arm was a subcutaneously placed catheter
so that the patient could not tell the difference during the three daily reinjections or subse‐
quently. The study has succeeded in differentiating the placebo group from the treatment
group in each location. The results have led to the conclusion that percutaneous lysis of
adhesions for patients with chronic lumbosacral radicular pain should be offered this proce‐
dure as first choice of treatment [62].
A systematic review of percutaneous adhesiolysis for chronic low back pain in post lumbar
surgery syndrome and spinal stenosis by S Helm II, et al, found effectiveness of the procedure
in both spinal stenosis and in post-lumbar surgery syndrome [59]. Additionally it was noted
that there have not been any hematomas reported. The results of the review support the use
of the procedure for the conditions listed.
The randomized double blind active control trial by Koh, et al, in patients with lateral spinal
canal stenosis demonstrated that the hypertonic saline showed significant short-term pain
relief [63]. Post procedure pain after the use of steroids has been a significant problem at the
first recognition of the effectiveness of percutaneous lysis of adhesions. Patients reported
significant post procedural pain prior to the introduction of hyaluronidase and hypertonic
saline to the sequence of injections. The parallel observation from the use of increased volume
of injection was that the hypertonic saline addition has not only reduced the radiculopathy
pain but also reduced the patient’s back pain. The volume increase was from the 2 mL per
injection range to the 5 mL range of each fluid component. The sequence of injections is first
contrast, followed by hyaluronidase, local anesthetic and steroid, and 20-30 minutes later, if
there was no motor block, the injection of hypertonic saline.
Manchikanti’s, et al, two-year follow-up of randomized controlled trial compared one-day
lysis of adhesions procedure to caudal epidural injection where the reinjection was triggered
by the patient’s pain relief dropping to below 50%. During the two-year study, the study group
received 6.4 ± 2.35 procedures and 82% of the patients received at least 50% pain relief, whereas
the caudal epidural injection had 5% similar rating. This strongly supports the effectiveness
of the percutaneous epidural lysis of adhesions [64].
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Park’s, et al, evaluation of severity of spinal stenosis with transforaminal adhesiolysis and
lumbar neuroforaminal stenosis showed effectiveness regardless of the intensity of lumbar
stenosis [65].
Park, et al, evaluated epidural neuroplasty for cervical disc herniation and demonstrated
effectiveness when conservative measures had failed. Park, et al, evaluated epidural neuro‐
plasty for cervical disc herniation and found safety and efficacy. There was no control arm to
the study, but the clinical results indicate reduction in cervical radiculopathy. The overall
clinical experience has showed us that there is a need for evaluation for cervicogenic facet pain
and appropriate treatment. Additionally, the anterior compartment between the anterior and
middle scalene muscles may be additional pain generators in patients that have pain secondary
to facet joint arthropathy [66].
Choi, et al, compared two patient groups with herniation of intervertebral discs and post
lumbar surgery syndrome. These results indicate better outcome in non-operated patients.
While not absolute prognostic predictor, the recommendation is that percutaneous adhesiol‐
ysis is a reasonable non-operative treatment option of herniation of intervertebral discs, spinal
stenosis, and post lumbar surgery syndrome [67].
The cost effectiveness of the Racz procedure compared favorably to other treatments for the
same conditions. The cost utility for 1 year of quality-adjusted life year (QALY) of USD is $2,652
for post-lumbar surgery syndrome and USD $2,649 for lumbar central spinal stenosis [68].
Epidural adhesiolysis has evolved over the years as an important treatment option for patients
with intractable cervical, thoracic, and low back and leg pain. Studies show that patients are
able to experience significant pain relief and restoration of function. Manchikanti's studies
show that the amount and duration of relief can be achieved by repeat procedures. Recent
prospective randomized double-blind studies on failed back surgery and spinal stenosis show
75% and 80% improvement in visual analog scale scores and functional improvements at 12
months' follow-up. There have been no negative studies to date where the lysis target was the
ventral-lateral epidural space. The one negative study used a 10 cm sacral mid-canal catheter
placement which was non-target specific [51]. This negative study was subsequently used as
the placebo group in a study performed by Manchikanti. Manchikanti’s study consisted of 3
treatment groups: placebo (sacral mid-canal catheter placement), target specific ventral-lateral
epidural without hypertonic saline and target specific ventral-lateral epidural with hypertonic
saline. The later two treatment groups had positive outcomes with the hypertonic saline group
superior, whereas, the placebo group did not [55]. The evolution in the recognition of the site-
specific importance of the catheter and medication delivery together with the fact that
physicians need to acquire the skills to be able to carry out the procedure led to the improved
outcomes seen in recent prospective randomized studies.
The management of failed back surgery syndrome and post laminectomy syndrome will likely
continue to be controversial among the multitude of practitioners who treat these patients.
However, in experienced hands, it is established as a reasonable option for many patients.
Percutaneous neuroplasty via a transforaminal approach evolved from the caudal approach.
Lysis of adhesions via the caudal approach involves introducing a catheter through the sacral
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hiatus and advancing it to the affected nerve root in the ventral-lateral epidural space. On the
other hand, transforaminal percutaneous neuroplasty achieves a midline catheter placement
in the epidural space that is able to target the two most heavily innervated structures in the
spine—the posterior annulus fibrosus and the posterior longitudinal ligament [5]. Apart from
a surgical approach, the ventral epidural structures have been otherwise inaccessible.
Endoscopy offers direct visualization of the affected nerve roots in addition to mechanical
adhesiolysis, and may become more mainstream as the technique is refined.
Facet pain is commonly associated with the postlysis period or after provocative testing a
month or so later if two-facet diagnostic blocks show efficacy. In addition to epidural lysis of
adhesions, the combined use of radiofrequency facet denervation gives us the best long-term
outcome.
Epidural adhesiolysis has been accepted as a treatment for post laminectomy syndrome, failed
back syndrome, and cervical and thoracic radicular syndromes. Additional studies are
underway to further refine the technique and indications. The combined use of long term
patient education for neural flossing exercises and the inclusion of the facet delayed treatment
in the algorithm further improves patient outcome. The identification of back pain provocation
by saline injection and the successful use of percutaneous neuroplasty in the treatment
represents hopeful promise for a cost effective treatment of back pain.
The increasing overall evidence is positive in the recommendation for use of percutaneous
lysis of adhesions based on high quality and observational clinical studies. The procedure
recommendation is for patients that failed conservative therapies. There are no negative
studies reported regarding the use of percutaneous adhesiolysis from the sacral to the cervical
areas.
The diagnosis and treatment of unusual rare complications must be within the scope of the
physician’s practice and the postoperative observational periods. Delayed secondary motor
block in patients where only caudal catheter is used to treat spinal stenosis needs to be
recognized as a consequence of fluid expansion from osmotic effect. Our preferred clinical
practice is heading in the direction of caudal and transforaminal catheter use at the level of
stenosis based on the utilization of the above-mentioned transforaminal catheter reports [4].
Clearly, additional studies will further prove safety and efficacy. Rare problems will come to
light, such as allergies, unusual loculations, or syrinx or congenital malformations. Thus, the
field shall become similar to any other advanced medical intervention. The quality of outcome
improves with improved training and experience. The most significant hazard is physicians
that are not trained, claiming to carry out percutaneous lysis procedure without appropriate
catheter placement. Therefore, recommendation is to describe the procedure and/or save
procedure fluoroscopic images that will prove appropriate catheter placement on anterior-
posterior and lateral views. Midline catheter placement for lysis of adhesions should be
avoided.
The treatment algorhythm for patients with leg and back pain, based on accumulating
evidence, should focus on radiculopathy and back pain. Next, a month later, the patient must
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be examined for diagnosis and treatment of other causes of back pain, such as facet joint related,
and pain from muscle spasms like gluteus medius, para spinal, quadratus lumborum, psoas,
and piriformis muscle related radiculopathy in the lumbosacral area. Significant undiagnosed
problems include trochanteric bursa related pain, cluneal nerve entrapments and hip joint
arthropathies. Similarly, the order of evaluation and treatment in the upper extremity ad‐
dressed should begin with radiculopathy, followed by facet joints and interscalene entrap‐
ments. Involvement through neural flossing exercises and appropriate instructions as outlined
in the above text has been remarkably well accepted by the patients.
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